Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

PURPOSE: High-dose methotrexate (HD-MTX) has been used to treat children with central nervous system tumors. Accumulation of MTX within pleural, peritoneal, or cardiac effusions has led to delayed excretion and increased risk of systemic toxicity. This retrospective study analyzed the association of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Chemother Pharmacol
Главные авторы: Wright, Karen D., Panetta, John C., Onar-Thomas, Arzu, Reddick, Wilburn E., Patay, Zoltan, Qaddoumi, Ibrahim, Broniscer, Alberto, Robinson, Giles, Boop, Frederick A., Klimo, Paul, Ward, Deborah, Gajjar, Amar, Stewart, Clinton F.
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282603/
https://ncbi.nlm.nih.gov/pubmed/25342291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2614-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы